The U.S. Food and Drug Administration (FDA) has refused to consider Moderna’s application for a new flu vaccine, which utilizes Nobel Prize-winning mRNA technology, the company announced on Tuesday.
In December 2025, Moderna submitted an application to the FDA to approve the first mRNA-based flu vaccine. Catherine Falls Commercial/Moment via Getty Images Ana Santos Rutschman, Villanova University ...
The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the ...
Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results